Academic Publications
Calarge C, Amushie C, Dinh S, Mills JA, Devaraj S, Barba-Villalobos G, Nguyen J, Garcia JM, Sisley S, Bacha F, Zemel B. Fluoxetine and Sertraline Inhibit Height Growth and Growth Hormone Signaling During Puberty. J Clin Psychopharmacol. 2024 Oct 14; doi: 10.1097/JCP.0000000000001922. [Epub ahead of print] PubMed PMID: 39392873; NIHMSID: NIHMS2023977.
Chen H, Lyu N, Chan W, De La Cruz A, Calarge C. Utilization and Predictors of Adjuvant Metformin for Children and Adolescents on Mixed Receptor Antagonists (Second-Generation Antipsychotics). J Am Acad Child Adolesc Psychiatry. 2023 Nov;62(11):1245-1255. doi: 10.1016/j.jaac.2023.02.017. Epub 2023 May 26. PubMed PMID: 37245706; PubMed Central PMCID: PMC10750998.
Ezenwabachili I, Deumic Shultz E, Mills JA, Ellingrod V, Calarge CA. Examining Whether Genetic Variants Moderate the Skeletal Effects of Selective Serotonin Reuptake Inhibitors in Older Adolescents and Young Adults. J Child Adolesc Psychopharmacol. 2023 Sep;33(7):260-268. doi: 10.1089/cap.2023.0007. Epub 2023 Aug 9. PubMed PMID: 37579130; PubMed Central PMCID: PMC10517324.
Calarge CA. Re: "Effects of Long-Term Sertraline Use on Pediatric Growth and Development: The Sertraline Pediatric Registry for The Evaluation of Safety (SPRITES)" by Kolitsopoulos et al. J Child Adolesc Psychopharmacol. 2023 Sep;33(7):294. doi: 10.1089/cap.2023.0034. Epub 2023 Aug 9. PubMed PMID: 37579182.
Calarge CA, Mills JA, Karaviti L, Teixeira AL, Zemel BS, Garcia JM. Selective Serotonin Reuptake Inhibitors Reduce Longitudinal Growth in Risperidone-Treated Boys. J Pediatr. 2018 Oct;201:245-251. doi: 10.1016/j.jpeds.2018.05.040. Epub 2018 Jun 27. PubMed PMID: 29958671; PubMed Central PMCID: PMC6153035.
Calarge CA, Acion L, Kuperman S, Tansey M, Schlechte JA. Weight gain and metabolic abnormalities during extended risperidone treatment in children and adolescents. J Child Adolesc Psychopharmacol. 2009 Apr;19(2):101-9. doi: 10.1089/cap.2008.007. PubMed PMID: 19364288; PubMed Central PMCID: PMC2715008.
Calarge CA, Devaraj S, Shulman RJ. Gut permeability and depressive symptom severity in unmedicated adolescents. J Affect Disord. 2019 Mar 1;246:586-594. PubMed PMID: 30605877.
Calarge CA, Mills JA, Karaviti L, Teixeira AL, Zemel BS, Garcia JM. Selective Serotonin Reuptake Inhibitors Reduce Longitudinal Growth in Risperidone-Treated Boys. J Pediatr. 2018 Oct;201:245-251. PubMed PMID: 29958671; PubMed Central PMCID: PMC6153035.
See a full list of publications.
